Alternative splicing: role of pseudoexons in human disease and potential therapeutic strategies

No abstract is available for this paper.

• Publication year

  2010

• Venue

  The FEBS Journal

• Publication date

  2010-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1742-4658.2009.07520.xPMID 20082636
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Alternative splicing: good and bad effects of translationally silent substitutions

  2010cited by this paper
• Alternative splicing: regulation of HIV‐1 multiplication as a target for therapeutic action

  2010cited by this paper
• Alternative splicing: global insights

  2010cited by this paper
• Novel aspects of alternative splicing

  2010cited by this paper
• A deep intronic mutation in FGB creates a consensus exonic splicing enhancer motif that results in afibrinogenemia caused by aberrant mRNA splicing, which can be corrected in vitro with antisense oligonucleotide treatment

  2009cited by this paper
• Clinical manifestation and a new ISCU mutation in iron-sulphur cluster deficiency myopathy.

  2009cited by this paper
• Antisense oligonucleotide treatment for a pseudoexon‐generating mutation in the NPC1 gene causing Niemann‐Pick type C disease b

  2009cited by this paper
• Characterization of a Disease-associated Mutation Affecting a Putative Splicing Regulatory Element in Intron 6b of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene*

  2009cited by this paper
• Splicing of designer exons reveals unexpected complexity in pre-mRNA splicing.

  2009cited by this paper
• Cryptic Exon Activation by Disruption of Exon Splice Enhancer

  2009cited by this paper
• Pseudoexon activation in the PKHD1 gene: a French founder intronic mutation IVS46+653A>G causing severe autosomal recessive polycystic kidney disease

  2009cited by this paper
• Disease‐causing mutations improving the branch site and polypyrimidine tract: Pseudoexon activation of LINE‐2 and antisense Alu lacking the poly(T)‐tail

  2009cited by this paper
• A Mutation that Creates a Pseudoexon in SOD1 Causes Familial ALS

  2009cited by this paper
• Antisense therapeutics for neurofibromatosis type 1 caused by deep intronic mutations

  2009cited by this paper
• Alu Exonization Events Reveal Features Required for Precise Recognition of Exons by the Splicing Machinery

  2009cited by this paper
• Functional analysis of three splicing mutations identified in the PMM2 gene: Toward a new therapy for congenital disorder of glycosylation type Ia

  2009cited by this paper
• Cellular stress and RNA splicing.

  2009cited by this paper
• A single‐base substitution within an intronic repetitive element causes dominant retinitis pigmentosa with reduced penetrance

  2009cited by this paper
• Characterization of a complex Duchenne muscular dystrophy–causing dystrophin gene inversion and restoration of the reading frame by induced exon skipping

  2009cited by this paper
• Intronic Alus Influence Alternative Splicing

  2008cited by this paper
• Nature and mRNA effect of 282 different NF1 point mutations: focus on splicing alterations

  2008cited by this paper
• An FBN1 pseudoexon mutation in a patient with Marfan syndrome: confirmation of cryptic mutations leading to disease

  2008cited by this paper
• Polypyrimidine tract binding protein controls the transition from exon definition to an intron defined spliceosome

  2008cited by this paper
• Genome-wide Analysis of Alternative Pre-mRNA Splicing*

  2008cited by this paper
• DMD pseudoexon mutations: splicing efficiency, phenotype, and potential therapy

  2008cited by this paper
• Splice mutation in the iron-sulfur cluster scaffold protein ISCU causes myopathy with exercise intolerance.

  2008cited by this paper
• Splicing regulation: from a parts list of regulatory elements to an integrated splicing code.

  2008cited by this paper
• A splice-site mutation and overexpression of MYO6 cause a similar phenotype in two families with autosomal dominant hearing loss

  2008cited by this paper
• A nonsense exon in the Tpm1 gene is silenced by hnRNP H and F.

  2008cited by this paper
• Alternative splicing: A missing piece in the puzzle of intron gain

  2008cited by this paper
• Structure and function of the Pre-mRNA splicing machine.

  2008cited by this paper
• Combinatorial Control of Exon Recognition*

  2008cited by this paper
• Polypyrimidine tract binding protein regulates alternative splicing of an aberrant pseudoexon in NF1

  2008cited by this paper
• Alternative splicing of Alu exons—two arms are better than one

  2008cited by this paper
• Myopathy with lactic acidosis is linked to chromosome 12q23.3-24.11 and caused by an intron mutation in the ISCU gene resulting in a splicing defect.

  2008cited by this paper
• Study of deep intronic sequence exonization in a Japanese neonate with a mitochondrial trifunctional protein deficiency.

  2008cited by this paper
• Aberrant 5′ splice sites in human disease genes: mutation pattern, nucleotide structure and comparison of computational tools that predict their utilization

  2007cited by this paper
• Protein‐ and mRNA‐based phenotype–genotype correlations in DMD/BMD with point mutations and molecular basis for BMD with nonsense and frameshift mutations in the DMD gene

  2007cited by this paper
• Pre-spliceosomal binding of U1 small nuclear ribonucleoprotein (RNP) and heterogenous nuclear RNP E1 is associated with suppression of a growth hormone receptor pseudoexon.

  2007cited by this paper
• A novel mutation of the NDUFS7 gene leads to activation of a cryptic exon and impaired assembly of mitochondrial complex I in a patient with Leigh syndrome.

  2007cited by this paper
• The birth of new exons: mechanisms and evolutionary consequences.

  2007cited by this paper
• Propionic and methylmalonic acidemia: antisense therapeutics for intronic variations causing aberrantly spliced messenger RNA.

  2007cited by this paper
• Global analysis of mRNA splicing.

  2007cited by this paper
• Mutation analysis of the ornithine transcarbamylase (OTC) gene in five Japanese OTC deficiency patients revealed two known and three novel mutations including a deep intronic mutation.

  2007cited by this paper
• Antisense-mediated exon skipping: a versatile tool with therapeutic and research applications.

  2007cited by this paper
• Searching for splicing motifs.

  2007cited by this paper
• Signals, pathways and splicing regulation.

  2007cited by this paper
• Comparative analysis of transposed element insertion within human and mouse genomes reveals Alu's unique role in shaping the human transcriptome

  2007cited by this paper
• RNA structure is a key regulatory element in pathological ATM and CFTR pseudoexon inclusion events

  2007cited by this paper
• Extensive in silico analysis of NF1 splicing defects uncovers determinants for splicing outcome upon 5′ splice‐site disruption

  2007cited by this paper
• A deep intronic mutation in the RB1 gene leads to intronic sequence exonisation

  2007cited by this paper
• Pseudo‐exon activation caused by a deep‐intronic mutation in the fibrinogen γ‐chain gene as a novel mechanism for congenital afibrinogenaemia

  2007cited by this paper
• Characterization of two unusual truncating PMM2 mutations in two CDG-Ia patients.

  2007cited by this paper
• Molecular characterization of Portuguese patients with mucopolysaccharidosis type II shows evidence that the IDS gene is prone to splicing mutations

  2006cited by this paper
• Alternative splicing and RNA selection pressure — evolutionary consequences for eukaryotic genomes

  2006cited by this paper
• Alternative splicing: new insights from global analyses.

  2006cited by this paper
• An Apparent Pseudo-Exon Acts both as an Alternative Exon That Leads to Nonsense-Mediated Decay and as a Zero-Length Exon

  2006cited by this paper
• Intronic alterations in BRCA1 and BRCA2: effect on mRNA splicing fidelity and expression

  2006cited by this paper
• Defective splicing, disease and therapy: searching for master checkpoints in exon definition

  2006cited by this paper
• Aberrant 3′ splice sites in human disease genes: mutation pattern, nucleotide structure and comparison of computational tools that predict their utilization

  2006cited by this paper
• Functional splicing assay shows a pathogenic intronic mutation in neurofibromatosis type 1 (NF1) due to intronic sequence exonization

  2006cited by this paper
• Origins and evolution of spliceosomal introns.

  2006cited by this paper
• Aberrant splicing in the ocular albinism type 1 gene (OA1/GPR143) is corrected in vitro by morpholino antisense oligonucleotides

  2006cited by this paper
• Multiple cryptic splice sites can be activated by IDS point mutations generating misspliced transcripts

  2006cited by this paper
• Mutations in the CEP290 (NPHP6) gene are a frequent cause of Leber congenital amaurosis.

  2006cited by this paper
• Chromatin, transcript elongation and alternative splicing

  2006cited by this paper
• A splice-supporting intronic mutation in the last bp position of a cryptic exon within intron 6 of the CYBB gene induces its incorporation into the mRNA causing chronic granulomatous disease (CGD).

  2006cited by this paper
• The snoRNA HBII-52 Regulates Alternative Splicing of the Serotonin Receptor 2C

  2006cited by this paper
• Spectrum of HSPG2 (Perlecan) mutations in patients with Schwartz‐Jampel syndrome

  2006cited by this paper
• Novel modes of splicing repression by PTB.

  2006cited by this paper
• Dichotomous splicing signals in exon flanks.

  2005cited by this paper
• Genetic analysis of three genes causing isolated methylmalonic acidemia: identification of 21 novel allelic variants.

  2005cited by this paper
• Making antisense of splicing.

  2005cited by this paper
• Nonsense-mediated mRNA decay in mammals

  2005cited by this paper
• A novel cryptic exon identified in the 3′ region of intron 2 of the human dystrophin gene

  2005cited by this paper
• Molecular analysis of a large cohort of patients with the hyper immunoglobulin M (IgM) syndrome.

  2005cited by this paper
• Function of alternative splicing.

  2005cited by this paper
• Silencer elements as possible inhibitors of pseudoexon splicing.

  2004cited by this paper
• Antisense strategies.

  2004cited by this paper
• Computational definition of sequence motifs governing constitutive exon splicing.

  2004cited by this paper
• Function of Alternative Splicing

  2004cited by this paper
• Influence of RNA Secondary Structure on the Pre-mRNA Splicing Process

  2004cited by this paper
• Dystrophinopathy caused by mid-intronic substitutions activating cryptic exons in the DMD gene.

  2004cited by this paper
• Pseudoexon activation in the DMD gene as a novel mechanism for Becker muscular dystrophy

  2003cited by this paper
• A homozygous splicing mutation causing a depletion of skeletal muscle RYR1 is associated with multi-minicore disease congenital myopathy with ophthalmoplegia.

  2003cited by this paper
• Two alternative exons can result from activation of the cryptic splice acceptor site deep within intron 2 of the dystrophin gene in a patient with as yet asymptomatic dystrophinopathy

  2003cited by this paper
• Partial deficiency of the C-terminal-domain phosphatase of RNA polymerase II is associated with congenital cataracts facial dysmorphism neuropathy syndrome

  2003cited by this paper
• Spectrum of FANCA mutations in Italian Fanconi anemia patients: Identification of six novel alleles and phenotypic characterization of the S858R variant

  2003cited by this paper
• Mechanisms of alternative pre-messenger RNA splicing.

  2003cited by this paper
• Novel types of mutation in the choroideremia (CHM) gene: a full-length L1 insertion and an intronic mutation activating a cryptic exon

  2003cited by this paper
• Partial deletion in the JK locus causing a Jk(null) phenotype.

  2002cited by this paper
• A new type of mutation causes a splicing defect in ATM

  2002cited by this paper
• Unusual deep intronic mutations in the COL4A5 gene cause X linked Alport syndrome

  2002cited by this paper
• Listening to silence and understanding nonsense: exonic mutations that affect splicing

  2002cited by this paper
• Analysis of BRCA1, TP53, and TSG101 germline mutations in German breast and/or ovarian cancer families.

  2002cited by this paper
• Alternative splicing in the alpha-galactosidase A gene: increased exon inclusion results in the Fabry cardiac phenotype.

  2002cited by this paper
• An unusual intronic mutation in the CYBB gene giving rise to chronic granulomatous disease.

  2001cited by this paper
• A novel 3600+11.5 kb C>G homozygous splicing mutation in a black African, consanguineous CF family

  2001cited by this paper
• Pseudoexon activation as a novel mechanism for disease resulting in atypical growth-hormone insensitivity.

  2001cited by this paper
• X-linked hypophosphatemia attributable to pseudoexons of the PHEX gene.

  2001cited by this paper

• Molecular treatment options for patients carrying KIAA0586/TALPID3 variants

  2025cites this paper
• Intronic variants impacting SLC12A1 gene splicing in Bartter syndrome type 1: Characterization of a novel deep intronic mutation via Whole-genome sequencing and minigene analysis.

  2025cites this paper
• Cell Modeling and Rescue of a Novel Non-coding Genetic Cause of Glycogen Storage Disease IX

  2025cites this paper
• 30 Years Since the Proposal of Exon Skipping Therapy for Duchenne Muscular Dystrophy and the Future of Pseudoexon Skipping

  2025cites this paper
• A Plot Twist: When RNA Yields Unexpected Findings in Paired DNA-RNA Germline Genetic Testing

  2025cites this paper
• To splice or not to splice: pseudoexons in neurological disease and opportunities for intervention.

  2025cites this paper
• Exploring RNA therapeutics for urea cycle disorders

  2024cites this paper
• c.640-814 T > C mutation in deep intronic region of alpha-galactosidase A gene is associated with Fabry disease via dominant-negative effect.

  2024cites this paper
• Pathogenic KIAA0586/TALPID3 variants are associated with defects in primary and motile cilia

  2024cites this paper
• Comprehensive splicing analysis of the alternatively spliced CHEK2 exons 8 and 10 reveals three enhancer/silencer‐rich regions and 38 spliceogenic variants

  2024cites this paper
• Successful skipping of abnormal pseudoexon by antisense oligonucleotides in vitro for a patient with beta-propeller protein-associated neurodegeneration

  2024cites this paper
• RNA structure in alternative splicing regulation: from mechanism to therapy

  2024cites this paper
• A panel of TDP-43-regulated splicing events verify loss of TDP-43 function in amyotrophic lateral sclerosis brain tissue

  2023cites this paper
• Regulating PCCA gene expression by modulation of pseudoexon splicing patterns to rescue enzyme activity in propionic acidemia

  2023cites this paper
• A panel of TDP-43-regulated splicing events verifies loss of TDP-43 function in amyotrophic lateral sclerosis brain tissue.

  2023cites this paper
• Differential exon usage and cryptic exon profiles of TDP-43 loss of function in amyotrophic lateral sclerosis brain tissue

  2023cites this paper
• A deep intronic splice variant of the COL4A5 gene in a Chinese family with X-linked Alport syndrome

  2023cites this paper
• Deep intronic PAH variants explain missing heritability in hyperphenylalaninemia.

  2023cites this paper
• Features of CFTR mRNA and implications for therapeutics development

  2023cites this paper
• Exon Skipping Through Chimeric Antisense U1 snRNAs to Correct Retinitis Pigmentosa GTPase-Regulator (RPGR) Splice Defect

  2022cites this paper
• Analysis of Pathogenic Pseudoexons Reveals Novel Mechanisms Driving Cryptic Splicing

  2022cites this paper
• The Contribution of COL4A5 Splicing Variants to the Pathogenesis of X-Linked Alport Syndrome

  2022cites this paper
• HNF1A：From Monogenic Diabetes to Type 2 Diabetes and Gestational Diabetes Mellitus

  2022cites this paper
• Alu-minating the Mechanisms Underlying Primate Cortex Evolution.

  2022cites this paper
• Antisense Oligonucleotide Rescue of Deep-Intronic Variants Activating Pseudoexons in the 6-Pyruvoyl-Tetrahydropterin Synthase Gene

  2022influential citation
• Transcriptional targets of amyotrophic lateral sclerosis/frontotemporal dementia protein TDP-43 – meta-analysis and interactive graphical database

  2022cites this paper
• Antisense oligonucleotide induced pseudoexon skipping and restoration of functional protein for Fukuyama muscular dystrophy caused by a deep-intronic variant.

  2022cites this paper
• Pseudoexon activation in disease by non‐splice site deep intronic sequence variation — wild type pseudoexons constitute high‐risk sites in the human genome

  2021influential citation
• Deep intronic variant in the ARSB gene as the genetic cause for Maroteaux–Lamy syndrome (MPS VI)

  2021cites this paper
• Role of Splicing Regulatory Elements and In Silico Tools Usage in the Identification of Deep Intronic Splicing Variants in Hereditary Breast/Ovarian Cancer Genes

  2021cites this paper
• Growth Hormone Receptor (GHR) 6Ω Pseudoexon Activation: A Novel Cause of Severe Growth Hormone Insensitivity

  2021cites this paper
• Antisense Oligonucleotide-Mediated Splice Switching: Potential Therapeutic Approach for Cancer Mitigation

  2021influential citation
• An Exploration of Mutagenesis in a Family with Cleidocranial Dysplasia without RUNX2 Mutation

  2021cites this paper
• A deep intronic variant activates a pseudoexon in the MTM1 gene in a family with X-linked myotubular myopathy

  2020cites this paper
• Benchmarking deep learning splice prediction tools using functional splice assays

  2020cites this paper
• GHR gene transcript heterogeneity may explain phenotypic variability in GHR pseudoexon (6Ψ) patients

  2020cites this paper
• Splicing mutations in inherited retinal diseases.

  2020cites this paper
• A synonymous mutation in exon 39 of FBN1 causes exon skipping leading to Marfan syndrome.

  2020cites this paper
• Large‐scale comparative evaluation of user‐friendly tools for predicting variant‐induced alterations of splicing regulatory elements

  2020cites this paper
• A Generic Assay to Detect Aberrant ARSB Splicing and mRNA Degradation for the Molecular Diagnosis of MPS VI

  2020cites this paper
• Targeting the splice factor kinase CLK1 in prostate cancer cells

  2020cites this paper
• Background splicing and genetic disease

  2020cites this paper
• Deep Intronic Mutation in SERPING1 Caused Hereditary Angioedema Through Pseudoexon Activation

  2020cites this paper
• Whole exome sequencing identifies a novel intron heterozygous mutation in TSC2 responsible for tuberous sclerosis complex

  2019cites this paper
• Machine Learning Approaches for the Prioritization of Genomic Variants Impacting Pre-mRNA Splicing

  2019cites this paper
• Profiling of prognostic alternative splicing in melanoma

  2019cites this paper
• Activation of cryptic splice sites in three patients with chronic granulomatous disease

  2019cites this paper
• Functional characterization and phenotypic spectrum of three recurrent disease-causing deep intronic variants of the CFTR gene.

  2019cites this paper
• Human Genomic Variants and Inherited Disease

  2019cites this paper
• Old gene, new phenotype: splice-altering variants in CEACAM16 cause recessive non-syndromic hearing impairment

  2018cites this paper
• Mutiple DICER1‐related lesions associated with a germline deep intronic mutation

  2018cites this paper
• Exonic mutations and exon skipping: Lessons learned from DFNA5

  2018cites this paper
• Nonclassical GH Insensitivity: Characterization of Mild Abnormalities of GH Action.

  2018cites this paper
• Screening of BRCA1/2 deep intronic regions by targeted gene sequencing identifies the first germline BRCA1 variant causing pseudoexon activation in a patient with breast/ovarian cancer

  2018cites this paper
• The regulation of incorrect splicing of ISCU in hereditary myopathy with lactic acidosis

  2018cites this paper
• Extensive Alternative Splicing of KIR Transcripts

  2018cites this paper
• Computational Modelling of Human Transcriptional Regulation by an Information Theory-based Approach

  2018cites this paper
• HnRNP L represses cryptic exons

  2018cites this paper
• Unraveling the genotypic and phenotypic complexities of genetic hearing loss

  2018cites this paper
• Rôle des miARN et des ARE-BP dans la mucoviscidose

  2018cites this paper
• Deep intronic mutations and human disease

  2017cites this paper
• Detailed molecular characterization of a novel IDS exonic mutation associated with multiple pseudoexon activation

  2017cites this paper
• RNA Editing for Muscular Dystrophy Therapy

  2017cites this paper
• Mutations of Pre-mRNA Splicing Regulatory Elements: Are Predictions Moving Forward to Clinical Diagnostics?

  2017cites this paper
• Whole gene sequencing identifies deep-intronic variants with potential functional impact in patients with hypertrophic cardiomyopathy

  2017cites this paper
• Normal and altered pre-mRNA processing in the DMD gene

  2017cites this paper
• RNA Editing for Muscular Dystrophy Therapy

  2016cites this paper
• Preand posttranscriptional genetic information modification in muscular dystrophy treatment

  2016cites this paper
• Characterization of the fibroblast growth factor receptor 2 splicing mechanism in triple-negative breast cancer

  2016cites this paper
• Analyse bio-informatique de données de séquençage de nouvelle génération pour l'étude transcriptomique d'enzymes du métabolisme

  2016cites this paper
• Complete androgen insensitivity syndrome caused by a deep intronic pseudoexon-activating mutation in the androgen receptor gene

  2016cites this paper
• Pseudoexons provide a mechanism for allele-specific expression of APC in familial adenomatous polyposis

  2016cites this paper
• Intron and Its Splicing Mechanism and Their Connection with Human Disease

  2016cites this paper
• Whole USH2A Gene Sequencing Identifies Several New Deep Intronic Mutations

  2016cites this paper
• The prevalent deep intronic c. 639+919 G>A GLA mutation causes pseudoexon activation and Fabry disease by abolishing the binding of hnRNPA1 and hnRNP A2/B1 to a splicing silencer.

  2016cites this paper
• Exome sequencing explained: a practical guide to its clinical application.

  2016cites this paper
• Splice-shifting oligonucleotide (SSO) mediated blocking of an exonic splicing enhancer (ESE) created by the prevalent c.903+469T>C MTRR mutation corrects splicing and restores enzyme activity in patient cells

  2015cites this paper
• TDP-43 affects splicing profiles and isoform production of genes involved in the apoptotic and mitotic cellular pathways

  2015cites this paper
• Understanding molecular mechanisms in propionic acidemia and investigated therapeutic strategies

  2015cites this paper
• A Unified Framework for the Prioritization of Variants of Uncertain Significance in Hereditary Breast and Ovarian Cancer Patients

  2015cites this paper
• Screening of accurate clones for gene synthesis in yeast.

  2015cites this paper
• Identification d'éléments régulateurs du gène CFTR et applications pour la mucoviscidose

  2015cites this paper
• Syddansk Universitet Splice-shifting oligonucleotide ( SSO ) mediated blocking of an exonic splicing enhancer ( ESE ) created by the prevalent c . 903 + 469 T > C MTRR mutation corrects splicing and restores enzyme activity in patient cells

  2015cites this paper
• Splicing analysis for exonic and intronic mismatch repair gene variants associated with Lynch syndrome confirms high concordance between minigene assays and patient RNA analyses

  2015cites this paper
• Characterization of an apparently synonymous F5 mutation causing aberrant splicing and factor V deficiency

  2015cites this paper
• Decoding abnormal splicing code in human diseases

  2015cites this paper
• Deciphering targeting rules of splicing modulator compounds: case of TG003

  2015cites this paper
• A unified analytic framework for prioritization of non-coding variants of uncertain significance in heritable breast and ovarian cancer

  2015cites this paper
• Pharmacodynamic assays to facilitate preclinical and clinical development of pre-mRNA splicing modulatory drug candidates

  2015cites this paper
• A novel dysferlin mutant pseudoexon bypassed with antisense oligonucleotides

  2014cites this paper
• The genetic basis for individual differences in mRNA splicing and APOBEC1 editing activity in murine macrophages

  2014cites this paper
• Antisense Mediated Splicing Modulation For Inherited Metabolic Diseases: Challenges for Delivery

  2014cites this paper
• NNT Pseudoexon Activation as a Novel Mechanism for Disease in Two Siblings With Familial Glucocorticoid Deficiency

  2014cites this paper
• Exon-Skipping Antisense Oligonucleotides to Correct Missplicing in Neurogenetic Diseases

  2014cites this paper
• A Sensitive Assay System To Test Antisense Oligonucleotides for Splice Suppression Therapy in the Mouse Liver

  2014cites this paper
• Identification and Functional Analysis of Alternatively Spliced Isoforms of Soluble Adenylyl Cyclase in Human Bronchial Epithelial Cells

  2014cites this paper
• Pseudoexon activation in the HMBS gene as a cause of the nonerythroid form of acute intermittent porphyria.

  2013cites this paper
• Dual Role of G-runs and hnRNP F in the Regulation of a Mutation-Activated Pseudoexon in the Fibrinogen Gamma-Chain Transcript

  2013cites this paper
• Direct Competition between hnRNP C and U2AF65 Protects the Transcriptome from the Exonization of Alu Elements

  2013cites this paper
• Role of Pseudoexons and Pseudointrons in Human Cancer

  2013cites this paper